Showing 1 - 20 results of 58 for search 'ELIAS JABBOUR', 查询时间: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy 由 Alfonso Quintás-Cardama, Hagop Kantarjian, Susan O’Brien, Elias Jabbour, Gautam Borthakur, Farhad Ravandi, Srdan Verstovsek, Jianqin Shan, Jorge Cortes
出版 2011-06-01
文件 -
10
-
11
Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy 由 Naveen Pemmaraju, Hagop Kantarjian, Jianqin Shan, Elias Jabbour, Alfonso Quintas-Cardama, Srdan Verstovsek, Farhad Ravandi, William Wierda, Susan O’Brien, Jorge Cortes
出版 2012-07-01
文件 -
12
P585: IMPACT OF MYELOID MUTATION PROFILE ON PCR RESPONSES AND SURVIVAL IN PATIENTS WITH CORE-BINDING FACTOR AML TREATED WITH FLAG BASED REGIMES 由 Jayastu Senapati, Aram Bidikian, Farhad Ravandi, Tapan Kadia, Courtney Dinardo, Guillermo Garcia-Manero, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Mark Brandt, Gautam Borthakur
出版 2023-08-01
文件 -
13
P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION. 由 Mahesh Swaminathan, Rashmi Kanagal-Shamanna, Farhad Ravandi, Tapan Kadia, Courtney Dinardo, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Sherry Pierce, John Matthew Villareal, Gautam Borthakur
出版 2023-08-01
文件 -
14
P672: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND T315I MUTATION AFTER FAILURE OF PRIOR THERAPIES 由 Aram Bidikian, Fadi Haddad, Koji Sasaki, Ghayas Issa, Tapan Kadia, Nitin Jain, Yesid Alvarado, Nicholas Short, Musa Yilmaz, Lucia Masarova, Elias Jabbour, Hagop Kantarjian
出版 2023-08-01
文件 -
15
Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States 由 Iman Abou Dalle, Hagop Kantarjian, Jan Burger, Zeev Estrov, Maro Ohanian, Srdan Verstovsek, Farhad Ravandi, Gautam Borthakur, Guillermo Garcia‐Manero, Elias Jabbour, Jorge Cortes
出版 2019-11-01
文件 -
16
The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis 由 Mahran Shoukier, Gautam Borthakur, Elias Jabbour, Farhad Ravandi, Guillermo Garcia-Manero, Tapan Kadia, Jairo Matthews, Lucia Masarova, Kiran Naqvi, Koji Sasaki, Srdan Verstovsek, Jorge Cortes
出版 2020-09-01
文件 -
17
-
18
A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leu... 由 Gautam Borthakur, Herve Dombret, Philippe Schafhausen, Tim Henrik Brummendorf, Nicolas Boissel, Elias Jabbour, Mariangela Mariani, Laura Capolongo, Patrizia Carpinelli, Cristina Davite, Hagop Kantarjian, Jorge E. Cortes
出版 2015-07-01
文件 -
19
Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leuke... 由 Naval Daver, Deborah Thomas, Farhad Ravandi, Jorge Cortes, Rebecca Garris, Elias Jabbour, Guillermo Garcia-Manero, Gautam Borthakur, Tapan Kadia, Michael Rytting, Marina Konopleva, Hagop Kantarjian, Susan O’Brien
出版 2015-05-01
文件 -
20
Ruxolitinib in combination with lenalidomide as therapy for patients with myelofibrosis 由 Naval Daver, Jorge Cortes, Kate Newberry, Elias Jabbour, Lingsha Zhou, Xuemei Wang, Sherry Pierce, Tapan Kadia, Koji Sasaki, Gautam Borthakur, Farhad Ravandi, Naveen Pemmaraju, Hagop Kantarjian, Srdan Verstovsek
出版 2015-08-01
文件